Last €146.25 EUR
Change Today +0.025 / 0.02%
Volume 86.0
HUM On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 1:03 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

humana inc (HUM) Snapshot

Open
€144.88
Previous Close
€146.22
Day High
€146.78
Day Low
€144.47
52 Week High
02/27/15 - €146.78
52 Week Low
04/17/14 - €75.14
Market Cap
21.9B
Average Volume 10 Days
87.8
EPS TTM
--
Shares Outstanding
149.6M
EX-Date
03/27/15
P/E TM
--
Dividend
€1.12
Dividend Yield
0.58%
Current Stock Chart for HUMANA INC (HUM)

humana inc (HUM) Details

Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Employer Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. This segment has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program and state-based Medicaid businesses. The Employer Group segment offers Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary benefit products, as well as administrative services only products, and health and wellness solutions directly to employer groups. The Healthcare Services segment provides pharmacy, provider services, home based services, integrated behavioral health services, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also offers military services, such as TRICARE South Region contract; Puerto Rico Medicaid; and closed-block long-term care insurance policies. As of December 31, 2014, it had approximately 13.8 million members in medical benefit plans; and approximately 7.7 million members in specialty products. The company was founded in 1961 and is headquartered in Louisville, Kentucky.

57,000 Employees
Last Reported Date: 02/18/15
Founded in 1961

humana inc (HUM) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.1M
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $764.4K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $904.8K
Chief Consumer Officer and Senior Vice Presid...
Total Annual Compensation: $653.4K
Advisor to the Office of Chief Financial Offi...
Total Annual Compensation: $637.0K
Compensation as of Fiscal Year 2013.

humana inc (HUM) Key Developments

Humana Inc. Declares Cash Dividend, Payable on April 24, 2015

Humana Inc. announced that its board of directors has declared a cash dividend to stockholders of $0.28 per share payable on April 24, 2015 to stockholders of record as of the close of business on March 31, 2015.

Summa Health System and Humana Launch Accountable Care in Akron

Humana Inc. announced that improved health and more coordinated services for the growing number of Humana Medicare Advantage (MA) members in Akron is the goal behind a new Accountable Care agreement between Summa Health System’s accountable care organization (ACO) – NewHealth Collaborative – and Humana Inc. Accountable care is a fast-growing model for health care service delivery and health care provider payment. The model focuses on creating health in addition to treating sickness, utilizes the primary care physician to coordinate care for the patient, offers treatment options based on proven standards of care and better controls costs through integrated care and reimbursement based on adherence to standards of care. The new Summa-Humana accountable care agreement includes value-based incentives tied to performance improvement that is expected to enable better patient care coordination, more cost effective, quality care and a world-class patient experience to Humana members throughout Northeastern Ohio. The value-based arrangement will offer more personalised care and a broad range of population management tools like, predictive analytics and chronic care, disease management and wellness programs. It also emphasizes quality outcomes with a focus on care coordination and leverages measures as defined by the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) for things such as diabetes care and treatment, breast cancer screenings, colorectal cancer screenings and high-risk medication.

Humana Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Reaffirms Earnings Guidance for the Full Fiscal 2015

Humana Inc. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company’s total revenues were $12,328 million compared to $10,187 million a year ago. Income from operations was $371 million compared to loss from operations of $14 million a year ago. Income before income taxes was $287 million compared to loss before income taxes of $49 million a year ago. Net income was $145 million or $0.94 per diluted share, compared to net loss of $30 million or $0.19 per diluted share, a year ago. Net cash provided by operating activities was $193 million compared to net cash used in operating activities of $16 million a year ago. Purchases of property and equipment were $167 million compared to $127 million a year ago. Adjusted pretax income of $324 million increased $130 million, or 67.0% versus $194 million for fourth quarter 2013 primarily due to improved year-over-year results in each of the company's business segments. Adjusted EPS of $1.09 for fourth quarter of 2014 increased $0.29 per share, or 36.3% versus $0.80 in fourth quarter of 2013, reflecting the improved pretax results as well as the impact of a lower weighted average share count due to the company's share repurchase program. For the year, the company’s total revenues were $48,500 million compared to $41,313 million a year ago. Income from operations was $2,362 million compared to $2,061 million a year ago. Income before income taxes was $2,170 million compared to $1,921 million a year ago. Net income was $1,147 million or $7.36 per diluted share, compared to $1,231 million or $7.73 per diluted share, a year ago. Net cash provided by operating activities was $1,618 million compared to $1,716 million a year ago. The year-over-year decline primarily reflected lower net income and the impact of changes in working capital including higher receivables associated with the 3Rs, partially offset by an increase in benefits payable from growth in membership. Purchases of property and equipment were $528 million compared to $441 million a year ago. Adjusted pretax income of $2.21 billion for fiscal year 2014 increased $43 million, or 2.0% versus $2.16 billion for fiscal year 2013 as higher earnings in the company's Healthcare Services segment were substantially offset by the anticipated lower year-over-year results in the company's Retail and Employer Group segments. As also anticipated, Adjusted EPS of $7.51 for fiscal year 2014 decreased $1.21 per share, or 13.9%, versus $8.72 in fiscal year 2013, primarily due to changes in segment pretax results, partially offset by the impact of share repurchase activity. The company reaffirmed earnings guidance for the full fiscal 2015. The company reaffirmed its estimate for EPS for the year ending December 31, 2015 to be in the range of $8.50 to $9.00. The company's 2015 EPS estimate reflects expected strong growth and operating efficiencies in the company's Medicare offerings, year-over-year improvement in the Healthcare Services businesses, break-even results in its HumanaOne business and reduced investment spending in state-based contracts, partially offset by the tax implications of the expected increase in the non-deductible health insurance industry fee and a reduction in 2015 Medicare rates. Consolidated revenues were expected to be in the range of $54.5 billion to $55.0 billion, revenues include expected interest income. Consolidated revenues were expected to be in the range of $54.5 billion to $55.0 billion, revenues include expected interest income. Effective tax rate was expected to be in the range of 48.75% to 49.75%. Cash flows from operations were expected to be in the range of $1.7 billion to $2.0 billion. Capital expenditures were expected to be in the range of $575 million to $625 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HUM:GR €146.25 EUR +0.025

HUM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $99.55 USD +0.24
Aflac Inc $62.25 USD +0.07
Anthem Inc $146.45 USD -0.27
Cigna Corp $121.63 USD +0.04
Prudential Financial Inc $80.85 USD -0.26
View Industry Companies
 

Industry Analysis

HUM

Industry Average

Valuation HUM Industry Range
Price/Earnings 22.3x
Price/Sales 0.5x
Price/Book 2.5x
Price/Cash Flow 16.6x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUMANA INC, please visit www.humana.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.